[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-334028-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-334028-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","spp1macrophages-and-fapfibroblasts-promote-the-progression-of-pmmr-gastric-cancer","SPP1+macrophages and FAP+fibroblasts promote the progression of pMMR gastric cancer","","Immunotherapy serves as a key treatment for gastric cancer patients with mismatch repair deficiency (dMMR), yet how MMR status shapes the tumor immune microenvironment (TiME) remains unclear. Single-cell RNA sequencing of 33 fresh tissue samples from 25 patients compared normal, dMMR, and pMMR tissues. pMMR tumors showed enrichment of a GC2 cell program linked to hypoxia, EMT, and angiogenesis, with worse survival associations. pMMR also displayed increased SPP1+ macrophage and FAP+ fibroblast infiltration, plus higher E2 endothelial activity in ECM remodeling and VEGF/HIF/angiogenesis pathways. Cell communications via VEGF, SPP1, and MIF formed a TiME characterized by hypoxia, pro-angiogenesis, and ECM remodeling, supporting targeted immunotherapy development.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/spp1macrophages-and-fapfibroblasts-promote-the-progression-of-pmmr-gastric-cancer/334028/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/spp1macrophages-and-fapfibroblasts-promote-the-progression-of-pmmr-gastric-cancer/334028.png","ImageObject",300,407,{"name":42,"@type":43},"Sage","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-29","2026-09-21",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",8,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"Why is MMR status important for immunotherapy in gastric cancer?","Question",{"text":63,"@type":64},"The immune checkpoint approach benefits dMMR gastric cancer, but the specific influence of mismatch repair status on the tumor immune microenvironment remains insufficiently understood.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How did the study analyze the tumor immune microenvironment?",{"text":68,"@type":64},"The researchers used single-cell RNA sequencing on 33 fresh tissue samples from 25 patients, covering normal tissue, dMMR tumors, and pMMR tumors, to characterize cellular and molecular components.",{"name":70,"@type":61,"acceptedAnswer":71},"What distinguishes the pMMR tumor immune microenvironment from the dMMR one?",{"text":72,"@type":64},"pMMR tumors showed higher prevalence of GC2 cells associated with hypoxia, EMT, and angiogenesis, along with increased infiltration of SPP1+ macrophages and FAP+ fibroblasts and greater E2 endothelial activity tied to VEGF/HIF/angiogenesis and ECM remodeling.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},334028,1790183464,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":55,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":109,"preview_page_count":4},687197207057,"https://ap-avatar.wpscdn.com/davatar_29158cc5080c5b710cf443261637dec0","[www. nature.com/scientificreports](www. nature.com/scientificreports)  \nOPEN  \nSPP1+macrophages and  \nFAP+fibroblasts promote the progression of pMMR gastric cancer  \nZhixiong Su1,2, Yufang He1,2, LijieYou1,2, Jingbo Chen1􀀍, Guifeng Zhang1􀀍 & Zhenhua Liu1􀀍  \nImmunotherapy has become a primary and secondary treatment for gastric cancer (GC) patients with mismatch repair deficiency (dMMR), and is used in both perioperative and advanced stages. The tumor immune microenvironment (TiME) is crucial for immunotherapy efficacy, yet the impact of MMR status on TiME remains understudied. We employed single-cell RNA sequencing (scRNA-seq) to analyze 33 fresh tissue samples from 25 patients, which included 10 normal tissues, 6 dMMR tumor tissues, and 17 pMMR tumor tissues, aiming to characterize the cellular and molecular components of theTiME. The proficient mismatch repair (pMMR) group displayed a significantly higher prevalence of a specific GC cell type, termed GC2, characterized by increased hypoxia, epithelial-mesenchymal transition (EMT), and angiogenic activities compared tothe dMMR group. GC2 cells overexpressed BEX3 and GPC3, and they significantly correlated with poorer survival. The pMMR group also showed increased infiltration of SPP1 +macrophages and FAP +fibroblasts, exhibiting strong hypoxic and pro-angiogenic features. Furthermore, a higher proportion of E2 endothelial cells, involved in extracellular matrix (ECM) remodeling and showing heightened VEGF pathway, HIF pathway, and angiogenesis activity, were identified in pMMR patients. Intercellular communication analyses revealed that GC2 cells, SPP1 +macrophages, FAP +fibroblasts, and E2 endothelial cells interact through VEGF, SPP1, and MIF signals, forming a TiME characterized by hypoxia, pro-angiogenesis, and ECM remodeling. This study uncoveredTiME heterogeneity among GC patients with different MMR states, highlighting that the pMMR TiME is distinguished by hypoxia, pro-angiogenesis, and ECM remodeling, driven by the presence of GC2 cells, SPP1 + macrophages, FAP +fibroblasts, and E2 endothelial cells. These findings are pivotal for developing targeted immunotherapies for GC patients with pMMR.  \nKeywords Mismatch repair, Gastric cancer, Immunotherapy, FAP+ fibroblasts, SPP1+macrophage  \nGastric cancer (GC) is the fifth most common cancer and the fourth leading cause of cancer-related mortality worldwide1. Despite the decline in incidence, projections show that the burden of GC is expected to increase 62% by 20402. Systemic chemotherapy continues to be the mainstay of treatment for metastatic GC, offering a median overall survival (OS) of approximately 12 months for patients undergoing conventional chemotherapy regimens3. Recent advancements in clinical trials have underscored the superior prognostic benefits of immune checkpoint inhibitors (ICIs) in both the perioperative and advanced stages of gastric cancer4–6. Notably, the CheckMate-6496,7 and KEYNOTE-8118,9 trials have illuminated the significant role of ICIs in enhancing survival outcomes for patients afflicted with advanced GC. Nonetheless, the determinants that account for the variability in the efficacy ofICIs among diverse patient populations remain subjects of ongoing investigation.  \nThe integrity of post-replicative DNA mismatch repair (MMR), facilitated by protein complexes including MutL homolog 1 (MLH1), MutS protein homolog 2 (MSH2), MutS homolog 6 (MSH6), and PMS1 homolog  \n2 (PMS2), is paramount for maintaining the fidelity of DNA replication10. This process is instrumental in identifying and rectifying single nucleotide mismatches that may otherwise evade the proofreading mechanisms during replication11. While MMR deficiency (dMMR) does not directly induce cellular proliferation, tumors with impaired MMR are characterized by an accumulation of mutations, a phenomenon that is linked to rapid disease progression yet paradoxically correlates with a more favorable prognosis in cancer12, 13. A meta-ana","cbCaiuwJKtSUTEfv","https://ap.wps.com/l/cbCaiuwJKtSUTEfv","pdf",9702358,16,"English","# Background\n# Methods\n## Single-cell RNA sequencing and sample groups\n# Results\n## GC2 enrichment in pMMR and survival association\n## Increased SPP1+ macrophages and FAP+ fibroblasts in pMMR\n## Endothelial E2 activity and pathway activation\n## Intercellular communication via VEGF, SPP1, and MIF\n# Conclusion and implications","[{\"question\":\"Why is MMR status important for immunotherapy in gastric cancer?\",\"answer\":\"The immune checkpoint approach benefits dMMR gastric cancer, but the specific influence of mismatch repair status on the tumor immune microenvironment remains insufficiently understood.\"},{\"question\":\"How did the study analyze the tumor immune microenvironment?\",\"answer\":\"The researchers used single-cell RNA sequencing on 33 fresh tissue samples from 25 patients, covering normal tissue, dMMR tumors, and pMMR tumors, to characterize cellular and molecular components.\"},{\"question\":\"What distinguishes the pMMR tumor immune microenvironment from the dMMR one?\",\"answer\":\"pMMR tumors showed higher prevalence of GC2 cells associated with hypoxia, EMT, and angiogenesis, along with increased infiltration of SPP1+ macrophages and FAP+ fibroblasts and greater E2 endothelial activity tied to VEGF/HIF/angiogenesis and ECM remodeling.\"}]","SPP1+macrophages and FAP+fibroblasts promote the progression of pMMR gastric cancer | PDF",1790005058]